GlassScriptPhysician profile
Gregory L Ortega
NPI 1720037989
$11,399.75
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $11.41 · 2021: $102 · 2022: $42.40 · 2024: $39.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $22.31 · Education: $17.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22.31 |
| Education | $17.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tosoh Bioscience, INC. | $10,812.00 | 2019 | |
| Seagen INC. | $187.23 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $98.50 | 2019 | |
| Janssen Biotech, INC. | $84.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $54.25 | 2019-2024 | Opdivo |
| Exelixis INC. | $48.26 | 2019 | |
| Kite Pharma, INC. | $33.27 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.34 | 2022 | |
| Agios Pharmaceuticals, INC. | $21.83 | 2019 | |
| Abbvie INC. | $19.06 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $17.02 | 2024 | Libtayo |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Ortega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.